Trial Outcomes & Findings for A Trial of Yoga in Pediatric Inflammatory Bowel Disease (NCT NCT03338894)

NCT ID: NCT03338894

Last Updated: 2023-09-18

Results Overview

The number of patients diagnosed with Inflammatory Bowel disease that have shown an improved health related quality of life (HRQOL) as assessed by the Pediatric Quality of Life survey after a structured yoga program, comparing pre-yoga HRQOL to post-yoga HRQOL. The Peds QOL age related surveys are validated pediatric questionnaires that measure general HRQOL in children ages 8-17 years. They consist of 23 questions in areas of social, school, emotional and physical functioning. The answers are scored on a 5 point scale and then reverse scored and linearly transformed to a scale of 1-100 scale.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

78 participants

Primary outcome timeframe

Compared difference from enrollment (time0) to start yoga class (time1), to difference from first yoga class (time1) to last yoga class (time2) 90 days, difference from first yoga class (time1) to 3 months after last yoga class (time 3) 180 days.

Results posted on

2023-09-18

Participant Flow

Study enrollment was offered during office or infusion visit. Recruitment began December 2017 and closed August 2019.

Participant milestones

Participant milestones
Measure
Yoga Group
Each subject will serve as their own control Yoga: 1 Hour yoga class
Overall Study
STARTED
78
Overall Study
COMPLETED
56
Overall Study
NOT COMPLETED
22

Reasons for withdrawal

Reasons for withdrawal
Measure
Yoga Group
Each subject will serve as their own control Yoga: 1 Hour yoga class
Overall Study
Withdrew, or not able to attend 9 or more classes, or did not complete final survey.
22

Baseline Characteristics

A Trial of Yoga in Pediatric Inflammatory Bowel Disease

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Yoga Group
n=56 Participants
Each subject will serve as their own control Yoga: 1 Hour yoga class
Age, Continuous
13 years
n=99 Participants
Sex: Female, Male
Female
39 Participants
n=99 Participants
Sex: Female, Male
Male
17 Participants
n=99 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
3 Participants
n=99 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
49 Participants
n=99 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
4 Participants
n=99 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=99 Participants
Race (NIH/OMB)
Asian
3 Participants
n=99 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=99 Participants
Race (NIH/OMB)
Black or African American
1 Participants
n=99 Participants
Race (NIH/OMB)
White
42 Participants
n=99 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=99 Participants
Race (NIH/OMB)
Unknown or Not Reported
10 Participants
n=99 Participants
Region of Enrollment
United States
56 participants
n=99 Participants
Inflammatory Bowel Disease Type
Crohn's Disease
41 Participants
n=99 Participants
Inflammatory Bowel Disease Type
Ulcerative Colitis/Inflammatory Bowel Disease unspecified
15 Participants
n=99 Participants

PRIMARY outcome

Timeframe: Compared difference from enrollment (time0) to start yoga class (time1), to difference from first yoga class (time1) to last yoga class (time2) 90 days, difference from first yoga class (time1) to 3 months after last yoga class (time 3) 180 days.

The number of patients diagnosed with Inflammatory Bowel disease that have shown an improved health related quality of life (HRQOL) as assessed by the Pediatric Quality of Life survey after a structured yoga program, comparing pre-yoga HRQOL to post-yoga HRQOL. The Peds QOL age related surveys are validated pediatric questionnaires that measure general HRQOL in children ages 8-17 years. They consist of 23 questions in areas of social, school, emotional and physical functioning. The answers are scored on a 5 point scale and then reverse scored and linearly transformed to a scale of 1-100 scale.

Outcome measures

Outcome measures
Measure
Yoga Group
n=54 Participants
Each subject will serve as their own control Yoga: 1 Hour yoga class
Pediatric Quality of Life Inventory
time 0 to time 1
2.14 score on a scale
Standard Deviation 8.79
Pediatric Quality of Life Inventory
time 1 to time 2
1.5 score on a scale
Standard Deviation 8.01
Pediatric Quality of Life Inventory
time 1 to time 3
2.8 score on a scale
Standard Deviation 10.24

SECONDARY outcome

Timeframe: Compared difference from enrollment (time0) to start yoga class (time1), to difference from first yoga class (time1) to last yoga class (time2) 90 days, difference from first yoga class (time1) to 3 months after last yoga class (time 3) 180 days.

This is a 10 item scale that measures a patient's general sense of perceived self-efficacy, aiming to predict coping with daily life as well as adaptation after stressful life events. The General Self Efficacy Scale is correlated to emotion, optimism, and work satisfaction. Negative coefficients were found for depression, stress, health complaints, burnout and anxiety. The total score is calculated by finding the sum of all item. For the General Self-Efficacy, the total score ranges between 10 to 40, with a higher score indicating more self-efficacy.

Outcome measures

Outcome measures
Measure
Yoga Group
n=54 Participants
Each subject will serve as their own control Yoga: 1 Hour yoga class
General Perceived Self Efficacy Scale
Time 0 to Time 1
0.27 score on a scale
Standard Deviation 3.89
General Perceived Self Efficacy Scale
Time 1 to Time 2
0.4 score on a scale
Standard Deviation 4.32
General Perceived Self Efficacy Scale
Time 1 to Time 3
1 score on a scale
Standard Deviation 3.603

Adverse Events

Yoga Group

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr. Alycia Leiby

Atlantic Children's Health/Atlantic Health Outpatient

Phone: 973--971-5676

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place